BR0309139A - Processo de tratamento - Google Patents

Processo de tratamento

Info

Publication number
BR0309139A
BR0309139A BR0309139-2A BR0309139A BR0309139A BR 0309139 A BR0309139 A BR 0309139A BR 0309139 A BR0309139 A BR 0309139A BR 0309139 A BR0309139 A BR 0309139A
Authority
BR
Brazil
Prior art keywords
treatment process
devazepide
analgesically effective
treatment
administration
Prior art date
Application number
BR0309139-2A
Other languages
English (en)
Inventor
Karen Jackson
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of BR0309139A publication Critical patent/BR0309139A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PROCESSO DE TRATAMENTO". A presente invenção refere-se a um processo de tratamento de um paciente requerendo terapia analgésica que compreende a administração de uma quantidade analgesicamente eficaz de devazepida. é também descrito o uso de devazepida na fabricação de um medicamento analgesicamente eficaz.
BR0309139-2A 2002-04-09 2003-04-09 Processo de tratamento BR0309139A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208129.7A GB0208129D0 (en) 2002-04-09 2002-04-09 Method of treatment
PCT/GB2003/001514 WO2003086409A1 (en) 2002-04-09 2003-04-09 The use of devazepide as analgesic agent

Publications (1)

Publication Number Publication Date
BR0309139A true BR0309139A (pt) 2005-02-01

Family

ID=9934506

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309139-2A BR0309139A (pt) 2002-04-09 2003-04-09 Processo de tratamento

Country Status (13)

Country Link
EP (1) EP1492540B1 (pt)
JP (1) JP2005529106A (pt)
AT (1) ATE375796T1 (pt)
AU (1) AU2003227858A1 (pt)
BR (1) BR0309139A (pt)
CA (1) CA2481272A1 (pt)
DE (1) DE60316927T2 (pt)
GB (1) GB0208129D0 (pt)
IL (1) IL164092A0 (pt)
MX (1) MXPA04009885A (pt)
NO (1) NO20043774L (pt)
PL (1) PL372986A1 (pt)
WO (1) WO2003086409A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325957D0 (en) * 2003-11-06 2003-12-10 Arakis Ltd The treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
CA2481272A1 (en) 2003-10-23
JP2005529106A (ja) 2005-09-29
IL164092A0 (en) 2005-12-18
EP1492540B1 (en) 2007-10-17
GB0208129D0 (en) 2002-05-22
PL372986A1 (en) 2005-08-08
DE60316927D1 (de) 2007-11-29
EP1492540A1 (en) 2005-01-05
AU2003227858A1 (en) 2003-10-27
WO2003086409A1 (en) 2003-10-23
ATE375796T1 (de) 2007-11-15
MXPA04009885A (es) 2004-12-07
DE60316927T2 (de) 2008-07-24
NO20043774L (no) 2005-01-06

Similar Documents

Publication Publication Date Title
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
NO20032027L (no) Effektive antitumorbehandlinger
CY1108217T1 (el) Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης
SE0400184D0 (sv) New therapeutical use
GB0020504D0 (en) Therapeutic method
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
EA199800866A1 (ru) Способ снятия боли
DK1077683T3 (da) Antidepressiv behandling
SE9902597D0 (sv) New use
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
GEP201606538B (en) Preoperative treatment of post operative pain
BR0309139A (pt) Processo de tratamento
AU2001236529A1 (en) Combination therapy for cancer
DE60125062D1 (de) Quetiapin zur Behandlung der Dyskinesie in nicht-psychotischen Patienten
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
DK1150981T3 (da) Terapeutisk necleosidforbindelse
UA36361A (uk) Спосіб лікування захворювань щитовидної залози
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA40393A (uk) Спосіб лікування хронічного обструктивного бронхіту
UA2699U (uk) Спосіб лікування автоімунного тиреоїдиту
DK1351676T3 (da) Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer
AR039862A1 (es) Uso de fexofenadina para la fabricacion de un medicamento para tratar un asma

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: INNOVATA PLC (GB)

Free format text: ALTERADO DE: ML LABORATORIES PLC

B25G Requested change of headquarter approved

Owner name: INNOVATA PLC (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060170294/RJ DE 10/11/2006.

B25A Requested transfer of rights approved

Owner name: PANOS THERAPEUTICS LIMITED (GB)

Free format text: TRANSFERIDO DE: INNOVATA PLC

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.